AKT2 and cancer: Using bioinformatics, we previously identified AKT2 and AKT3, both of which are key proteins in the AKT signaling pathway, as potential downstream target genes of miR-29b, indicating that miR-29b-mediated effects on the AKT signaling pathway is probably involved in cancer glycolysis and the Warburg effect.